Faheem Hasnain

Insider Reports History

Entity
Individual
Location
14 Cambridge Center, Cambridge, Massachusetts
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Faheem Hasnain:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gossamer Bio, Inc. President & CEO, Director Common Stock 5.41M $3.64M $0.67 Jun 21, 2024 By family trust
Gossamer Bio, Inc. President & CEO, Director Common Stock 120K $80.9K $0.67 Jun 21, 2024 Direct
Gossamer Bio, Inc. President & CEO, Director Stock Option (Right to Buy) 1.31M Jan 2, 2024 Direct
Gossamer Bio, Inc. President & CEO, Director Common Stock Purchase Warrants 135K Jul 24, 2023 By family trust
Kura Oncology, Inc. Director Option to purchase common stock 26K Jun 5, 2024 Direct
Mirati Therapeutics, Inc. Director Common Stock 0 $59.02 Jan 23, 2024 Direct
Mirati Therapeutics, Inc. Director Option to Purchase Common Stock 0 Jan 23, 2024 Direct

Insider Reports Filed by Faheem Hasnain

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GOSS Gossamer Bio, Inc. Jun 21, 2024 1 $250K 4 Jun 24, 2024 President & CEO, Director
KURA Kura Oncology, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
GOSS Gossamer Bio, Inc. Mar 27, 2024 1 -$26.8K 4 Mar 28, 2024 President & CEO, Director
MRTX Mirati Therapeutics, Inc. Jan 23, 2024 6 $0 4 Jan 23, 2024 Director
GOSS Gossamer Bio, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 President & CEO, Director
MRTX Mirati Therapeutics, Inc. Dec 29, 2023 1 $570K 4 Jan 3, 2024 Director
GOSS Gossamer Bio, Inc. Nov 20, 2023 1 $0 4 Nov 22, 2023 President & CEO, Director
MRTX Mirati Therapeutics, Inc. Aug 11, 2023 1 $300K 4 Aug 14, 2023 Director
GOSS Gossamer Bio, Inc. Jul 24, 2023 2 $1M 4 Jul 26, 2023 President & CEO, Director
KURA Kura Oncology, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
GOSS Gossamer Bio, Inc. May 5, 2023 1 $0 4 May 9, 2023 President & CEO, Director
GOSS Gossamer Bio, Inc. Mar 20, 2023 4 $1M 4 Mar 22, 2023 President & CEO, Director
MRTX Mirati Therapeutics, Inc. Jan 20, 2023 2 $0 4 Jan 24, 2023 Director
GOSS Gossamer Bio, Inc. Dec 7, 2022 1 $0 4 Dec 9, 2022 President & CEO, Director
GOSS Gossamer Bio, Inc. Jul 15, 2022 1 $1M 4 Jul 15, 2022 President & CEO, Director
KURA Kura Oncology, Inc. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
GOSS Gossamer Bio, Inc. Mar 23, 2022 1 -$170K 4 Mar 24, 2022 President & CEO, Director
MRTX Mirati Therapeutics, Inc. Jan 14, 2022 2 $0 4 Jan 18, 2022 Director
GOSS Gossamer Bio, Inc. Jan 6, 2022 1 $0 4 Jan 10, 2022 President & CEO, Director
KURA Kura Oncology, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director